Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: An interim analysis

British Journal of Psychiatry

Volumn 181, Issue SUPPL. 43, 2002, Pages

  Good, Kimberley P ^a   Kiss, I ^a   Buiteman, C ^a   Woodley, H ^a   Rui, Q ^a   Whitehorn, D ^a   Kopala, L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; LOXAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTENTION; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PRODUCTIVITY; PSYCHOSIS; SCORING SYSTEM; ADOLESCENT; PSYCHOLOGY; SCHIZOPHRENIA; SPEECH;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION; COGNITION; DIBENZOTHIAZEPINES; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SPEECH;

EID: 0036728163     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.181.43.s45     Document Type: Article

References (22)

1. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: A longitudinal study
2. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
3. Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"?
4. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine
5. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
6. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic in-patients
7. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
8. The positive and negative syndrome scale (PANSS) for schizophrenia
9. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and metaanalysis
10. Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients
11. Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: Response to low-dose risperidone
12. Effects of clozapine on cognitive function in schizophrenia
13. Memory and attention deficits in drug naive patients with schizophrenia
14. Risperidone in the treatment of schizophrenia
15. Neuropsychology of psychosis
16. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone or haloperidol
17. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol
18. Attentional improvement following quetiapine fumarate treatment in schizophrenia
19. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia
20. Cognitive dysfunction in schizophrenia and its importance to outcome: The place of atypical antipsychotics in treatment